HBM HOLDINGS-B (02142): Chen Youchen appointed as Executive Director
Heptagon Pharmaceuticals-B (02142) announced that Dr. Rong Yiping has resigned as executive director for personal reasons, effective from August 27, 2026.
HBM HOLDINGS-B (02142) announced that Dr. Rong Yiping has resigned as Executive Director for personal reasons, effective August 27, 2026.
Following the recommendations of the Nomination Committee of the Board of Directors, Mr. Chen Youchen and Dr. Liu Yi have been appointed as Executive Directors, effective from the date of resignation.
After Dr. Rong's resignation, he will no longer serve as the authorized representative of the company under Rule 3.05 of the Listing Rules. Mr. Chen Youchen has been appointed as the authorized representative, effective from the date of resignation.
Related Articles

Y.T. REALTY (00075) released its interim results, with a shareholder loss of HKD 296 million, an increase of 342.16% year-on-year.

SDITC (01697) announced its mid-term results, with a net loss of approximately 119 million yuan, turning from profit to loss year-on-year.

ANHUI EXPRESSWAY (00995) released its interim results, with net profit attributable to shareholders reaching 1.008 billion yuan, a year-on-year increase of 4.87%.
Y.T. REALTY (00075) released its interim results, with a shareholder loss of HKD 296 million, an increase of 342.16% year-on-year.

SDITC (01697) announced its mid-term results, with a net loss of approximately 119 million yuan, turning from profit to loss year-on-year.

ANHUI EXPRESSWAY (00995) released its interim results, with net profit attributable to shareholders reaching 1.008 billion yuan, a year-on-year increase of 4.87%.

RECOMMEND





